The utility of pharmacogenetic testing to support the treatment of bipolar disorder

The utility of pharmacogenetic testing to support the treatment of bipolar disorder

Marta Ielmini,1 Nicola Poloni,1 Ivano Caselli,1 Jordi Espadaler,2 Miquel Tuson,2 Alessandro Grecchi,3 Camilla Callegari1 1Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy; 2AB-BIOTICS S.A, R&D Unit, Sant Cugat del Valles, Barcelona, Spain; 3AS...

Full description

Bibliographic Details
Main Authors: Ielmini M, Poloni N, Caselli I, Espadaler J, Tuson M, Grecchi A, Callegari C
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Pharmacogenetics testing
bipolar disorder
personalized medicine
pharmacogenetics
adverse events
Online Access:https://www.dovepress.com/the-utility-of-pharmacogenetic-testing-to-support-the-treatment-of-bip-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/the-utility-of-pharmacogenetic-testing-to-support-the-treatment-of-bip-peer-reviewed-article-PGPM

Similar Items